RENEW ENERGY GLOBAL PLC (RNW): what the price assumes
In the published model solve dated 2026-Q2, anchored at $6.11, RENEW ENERGY GLOBAL PLC (RNW) is priced for today's economics sustained for ~8.0 years. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-06-28.
Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/RNW
Headline
| Field | Value |
|---|---|
| Ticker | RNW |
| Company | RENEW ENERGY GLOBAL PLC |
| Current price | $6.11/sh |
What The Price Assumes (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | whole-company |
| Must persist for | 8.0y |
| Multiple paid | 81x operating income |
Solve inputs: computed at a 7% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~2.6 years (computed at the 7% minimum rate; the CAPM rate 4.7% sits below it).
Reconcile: at the x-ray's 9.3% required return this reads ~13.4 years; the models below use their own rates.
How unusual the bet is: elevated (limited comparison data)
| Reference | Value |
|---|---|
| sustained it ~8 years at this level | 26% |
| implied end-window share | 0% |
Valuation X-Ray
Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 6.17x | 5 | expensive |
| Earnings | 1.46x | 3 | expensive |
| Relative | 1.30x | 4 | expensive |
| Growth | 0.48x | 2 | justifies |
Families that justify the price: Growth Families that call it expensive: Asset
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 4.9%); the inversion above states its own rate.
Per-Model Detail (n=14)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | — | — | no | — |
| DCF Exit Multiple | Growth | $36.03 | 0.17x | yes | Exit EV/EBITDA: 23.4x / 25.4x / 27.4x (bear / base = today's held flat / bull), 6yr |
| Relative Valuation | Relative | $4.47 | 1.37x | yes | P/E 26.32x (blended: static sector reference 20x + trailing (TTM) 41x), scenarios: 21.7x / 26.3x / 30.9x (bear / base = reference held flat / bull), EV/EBITDA 16.72x |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | $1.61 | 3.80x | yes | BV/sh $4.23, ROE (TTM) 3.5%, ke 9.3% |
| Two-Stage Excess Return | Asset | $0.99 | 6.17x | yes | 5yr excess ROE then converge to ke=9.3% |
| Discounted Future Market Cap | Growth | $7.67 | 0.80x | yes | Rev $1.3B, growth 12% (input: historical growth; tapered), Terminal P/S: 1.4x / 1.7x / 2.0x (bear / base = today's held flat / bull, cap 8x) |
| Peter Lynch Fair Value | Relative | $4.55 | 1.34x | yes | EPS $0.13, growth 35% (input: historical EPS growth), PEG=1.17 (Fair) |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | $0.01 | 611.00x | yes | Normalized EBIT (4y avg op income, one-time charges added back) $0.01B × (1−40%) / WACC 4.9% → EPV (no growth) (excluded from median) |
| Residual Income | Asset | $0.75 | 8.15x | yes | BV $4.23 + 5yr PV of (ROE (TTM) 3.5% − Kₑ 9.3%) × BV; BV grows 2.3%/yr |
| Graham Number | Asset | $3.52 | 1.74x | yes | √(22.5 × EPS $0.13 × BVPS $4.23) — Graham's conservative floor |
| EV/EBITDA Relative | Relative | $0.01 | 611.00x | yes | EBITDA $0.36B × sector EV/EBITDA 13.0x (excluded from median) |
| FCF Yield | Earnings | $4.47 | 1.37x | yes | FCF $791.0M / Kₑ 9.3% — zero-growth perpetuity |
| SBC-Adj FCF Yield | Earnings | — | — | no | — |
| Ben Graham Formula | Earnings | $4.19 | 1.46x | yes | EPS $0.13 × (8.5 + 2×15.0%) × (4.4 / 5.3%) |
| ROIC-Justified P/B | Asset | $0.73 | 8.37x | yes | BV $4.23 × (ROIC 0.8% / WACC 4.9%) |
| P/Sales Sector | Relative | $8.80 | 0.69x | yes | Revenue $1.28B × sector P/S 2.5x |
| PEG Fair Value | Relative | $4.88 | 1.25x | yes | EPS $0.13 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x |
| Earnings Yield | Earnings | $1.41 | 4.33x | yes | EPS $0.13 / required return 9.3% (Rf 4.3% + ERP 5.0%) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Net debt | $7.2b |
| Net debt / NOPAT (after-tax) | 134.63x |
| Net debt / operating income (pre-tax) | 60.99x |
| Interest coverage | 0.2x |
| Burning cash | no |
Bullet Takeaways
- ReNew Energy Global is one of India's largest renewable power producers, building and operating solar and wind capacity under long-term contracts, so its value is the cash flow from a growing fleet of generating assets rather than near-term accounting profit.
- The single most decisive number is operating capacity: the portfolio reached 12.8 GW, up 25 percent year over year, and the company is moving upstream into solar-cell manufacturing, so the rate of profitable capacity addition drives the entire thesis.
- The defining risk is the debt: building power plants is capital-heavy, and the company carries multi-billion-dollar net debt against thin accounting operating income, so the bet depends on rising EBITDA outpacing the interest and on continued access to capital.
Bull Case
The number that anchors the bull case is capacity, because for a renewable power producer installed gigawatts are the asset that compounds. ReNew's operating portfolio reached 12.8 GW, a 25 percent increase year over year, with 2.4 GW of new capacity commissioned in the most recent fiscal year. Each gigawatt comes with long-term power-purchase contracts that turn sunshine and wind into contracted, inflation-resistant cash flow for decades. A company adding capacity at a double-digit annual rate in a country with India's structural demand for power is building an annuity stream that the current accounting earnings, depressed by the heavy depreciation and interest that come with new assets, do not yet reflect.
The financial trajectory is bending the right way. Fiscal 2026 revenue grew 36 percent to roughly ₹132 billion, net income rose 162 percent to about ₹10 billion, and adjusted EBITDA, the measure that matters for a capital-intensive utility, grew 31 percent to roughly ₹75 billion, above the company's prior guidance. Crucially, leverage declined even as the fleet grew, and management raised its EBITDA outlook for the next fiscal year. Rising EBITDA with falling leverage is the combination that de-risks a debt-funded infrastructure builder: the cash flow that services and reduces the debt is growing faster than the debt itself.
The strategic move upstream adds a second growth lever. ReNew is building toward an additional 4 GW of solar-cell manufacturing capacity, which would let it capture more of the value chain and reduce dependence on imported components, a meaningful edge as India pushes domestic content in renewables. The valuation methods reflect a business priced well below the cash flow its assets can generate: the relative-multiple and forward-growth methods land at or above the price, and a free-cash-flow lens reads the stock as inexpensive relative to the cash the fleet throws off. For an investor who can underwrite the debt and the execution, a leading position in one of the world's largest renewable-energy build-outs, with EBITDA rising and leverage falling, is the growth-infrastructure bet the bull case rests on.
Bear Case
The plain truth a holder has to confront is how little accounting profit sits beneath this price relative to how much debt does. ReNew earns a return on equity of only about 3.5 percent, and its trailing operating income is a thin sliver against net debt of roughly $7 billion, so the conventional coverage and leverage measures are stretched to the point of being alarming on their face. Building power plants consumes capital years before the cash flow arrives, which is the nature of the business, but it also means the equity is a thin, highly geared claim sitting on top of a very large debt stack. If the cost of that debt rises, or if EBITDA growth stalls, the equity bears the squeeze first and hardest.
The valuation, read honestly, is demanding once the asset-based lens is taken seriously. The asset-based and earnings-power methods read the stock as expensive, because on book value and normalized earnings the business is not yet creating value above its cost of capital, earning a return well below the roughly 9 percent that capital costs. On company-wide operating income the price implies growth held at the self-funding ceiling for years, a pace only about a third of comparable fast-growers have sustained. The bull leans on EBITDA and capacity; the bear points out that EBITDA is not free cash flow when a company is plowing every rupee back into new plants and servicing a heavy debt load, and that the gap between reported EBITDA and what reaches equity holders is exactly where capital-intensive growth stories disappoint.
The operating risks are real and largely external. Management itself has flagged grid-expansion delays, project curtailments, and demand-side regulations as ongoing risks, all of which can strand or slow the very capacity the thesis depends on; a plant that cannot evacuate its power to the grid earns nothing while still carrying its debt. India's renewable build-out is also competitive and policy-sensitive, with tariffs set in auctions that can compress returns. Layer the leverage, the sub-cost-of-capital return, the dependence on continued capital access, and the regulatory and grid risks, and the price asks the buyer to underwrite a long, clean, debt-funded expansion in an emerging market, with little accounting earnings to cushion a misstep.
Valuation
ReNew is a capital-intensive renewable power producer, and the right lens is the cash flow and EBITDA of its generating fleet, not its accounting operating income. On that operating-income basis the price looks extreme, implying growth held at the self-funding ceiling for years, but that is partly an artifact of how much depreciation and interest a young, fast-growing asset base carries; the more telling measures are the 12.8 GW of operating capacity and the roughly ₹75 billion of adjusted EBITDA that grew 31 percent in the latest year.
The methods split exactly as they do for a leveraged infrastructure builder. The asset-based and earnings-power methods read the price as expensive, because the business earns a return on equity around 3.5 percent, below its cost of capital on current book economics. The relative-multiple and forward-growth methods reach the price, crediting the capacity growth and the EBITDA trajectory, and a free-cash-flow lens reads the stock as inexpensive on the cash the fleet generates. The disagreement is the whole question: value ReNew on what it earns today and it looks rich; value it on the contracted cash flow of a growing asset base and it looks cheap.
Solvency is where the caution must live, and it is not optional for this name. Net debt is roughly $7 billion against thin trailing operating income, so the conventional coverage ratios are deeply stretched, and the equity is a geared claim on the spread between rising EBITDA and a heavy interest bill. The mitigant the company points to is that leverage is declining even as capacity grows, and EBITDA is rising faster than debt; the risk is that any interruption to that trajectory, from grid delays, curtailment, or higher funding costs, falls on the equity first. The price is underwriting that the EBITDA-up, leverage-down path continues long enough for the contracted cash flows to validate the asset base.
Catalysts
Fiscal 2026 was a record year for the operating business. ReNew reported revenue of roughly ₹132.2 billion, up 36 percent year over year, net income of about ₹10.4 billion, up 162 percent, and adjusted EBITDA of roughly ₹74.8 billion, up 31 percent and above prior guidance. The operating portfolio grew 25 percent to 12.8 GW, with 2.4 GW of new capacity commissioned during the year.
The forward catalysts are capacity, manufacturing, and deleveraging. The company plans to add about 4 GW of solar-cell manufacturing capacity by December 2026, moving upstream in the value chain, and management raised its EBITDA projection for the next fiscal year while targeting further leverage reduction. Management also flagged ongoing risks from grid-expansion delays, project curtailments, and demand-side regulations. The signals to track are the pace of profitable capacity commissioning, progress on the manufacturing ramp, and continued reduction in net debt-to-EBITDA, the three measures that determine whether the contracted cash flows grow into the debt the equity sits above.
Peer Cohorts (Per Segment, With Filing Citations)
Core business (reported)
- STRA (Strategic Education, Inc.)
- FY2025 10-K: $112.7 million in 2024 compared to $69.8 million in 2023 due to the factors discussed above. Non-GAAP Financial Measures We use certain financial measures including Adjusted Total Costs and Expenses, Adjusted Income from Operations, Adjusted Operating Margin, Adjusted Income Before Income Taxes, Adjusted Net Income,…
- FY2025 10-K: …learning modalities, we face increasing competition for students from traditional colleges, including colleges with well-established reputations for excellence and colleges in states that offer various forms of "free college" programs. As online learning matures as a modality for education delivery across higher…
- PGNY (Progyny, Inc.)
- FY2025 10-K: …profit and gross margin will continue to be affected by various factors including the geographic location where treatments are performed, as well as pricing with each of our clients, provider clinics, labs, specialty pharmacies and pharmaceutical companies, all of which are negotiated separately, have different…
- FY2025 10-K: …10-K and our other filings with the U.S. Securities and Exchange Commission, or the SEC, before making an investment decision regarding our common stock. • We may fail to meet our publicly announced guidance or other expectations about our business and future results of operations, which would cause our stock price…
- WD (Walker & Dunlop, Inc.)
- FY2025 10-K: …loan carries an interest rate of SOFR plus 1.87 % and will require our subsidiary to make insignificant monthly principal payments until October 1, 2029 at which point the subsidiary will make a $ 33.1 million principal payment. NOTE 17-OTHER REVENUES, OTHER OPERATING EXPENSES, AND ASSET IMPAIRMENTS AND OTHER…
- FY2025 10-K: 41) 37 % Principal collected on loans held for investment - 55,701 (55,701) (100) Purchases of pledged AFS securities, net of proceeds from prepayments (20,366) (41,857) 21,491 (51) Originations and repurchase of loans held for investment (24,381) (37,928) 13,547 (36) Other…
- AVO (AVO)
- FY2025 10-K: …rates between the U.S. dollar and these local currencies usually do not have a significant impact on our gross margin because the impact typically affects our pricing by comparable amounts. Our margin exposure to exchange rate fluctuations is short-term in nature, as our sales price commitments are generally limited…
- FY2025 10-K: …its Marketing & Distribution segment during the first quarter of 2025. In connection with the closure, we recognized approximately $2.7 million in charges for fiscal 2025. Charges consisted of accelerated depreciation expense of property, plant and equipment, accelerated amortization expense of operating lease…
- AM (ANTERO MIDSTREAM CORPORATION)
- FY2025 10-K: …basis. (2) Amounts include charges for accretion of asset retirement obligations, loss on settlement of asset retirement obligations and loss (gain) on sale of assets, as applicable, which represent segment operating expenses that are not considered significant . F-32 Table of Contents ANTERO MIDSTREAM CORPORATION…
- FY2025 10-K: Other assets, net 476 Total $ 383,636 Current liabilities: Accounts payable-third party $ 634 Accrued liabilities 1,663 Long-term liabilities: Other long-term liabilities 3,021 Total $ 5,318 (4) Intangibles All customer relationships are subject to…
- KGS (Kodiak Gas Services, Inc.)
- FY2025 10-K: …operations, from revenues directly attributable to the segment. Adjusted gross margin is a key tool used by the CODM for annual budgeting, monthly forecasting, and determining how to allocate capital and resources across the segments. Revenue includes only sales to external customers. The following table represents…
- FY2025 10-K: …elsewhere in this Annual Report. Non-GAAP Financial Measures Management uses a variety of financial and operating metrics to analyze our performance. These metrics are significant factors in assessing our operating results and profitability and include the non-GAAP financial measures of adjusted gross margin,…
- TDW (TIDEWATER INC)
- FY2025 10-K: …a material adverse effect on our current and future business, financial position, results of operations, and cash flows. Our customer base has undergone consolidation and additional consolidation is possible. Consolidation is common in the oil and gas industry and likely to continue in the future. Consolidation…
- FY2025 10-K: …which we operate, the impact of legislative and regulatory actions on how we conduct our business and other factors, all of which are beyond our control. Lower levels of offshore exploration and development activity and spending by our customers globally directly and significantly have impacted, and may continue to…
- AIN (AIN)
- FY2025 10-K: …business plan values with Safran for the subsequent full twelve-month calendar year. Orders included in our backlog may be modified, canceled, or rescheduled by our customers, although customers may incur cancellation penalties as defined in the terms of such customer contracts; and which such terms may vary from…
- FY2025 10-K: …and lower than anticipated sales pricing. This decline is slightly offset by a strong performance within the European market, particularly related to the drying and pressing programs. Further, changes in currency translation rates had the effect of increasing Net revenues $1.2 million. Gross Profit Gross profit…
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.
Sources
ReNew Energy Global FY2026 results · ReNew Energy Global FY2026 results / earnings call · ReNew Energy Global FY2026 earnings call